{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "currency": "USD", "exchange": "NMS", "shortName": "Pharvaris N.V.", "longName": "Pharvaris N.V.", "messageBoardId": "finmb_402951024", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "REGULAR", "regularMarketChangePercent": 2.6570082, "regularMarketPrice": 8.5, "firstTradeDateMilliseconds": 1612535400000, "priceHint": 2, "regularMarketChange": 0.22000027, "regularMarketTime": 1684253396, "regularMarketDayHigh": 8.96, "regularMarketDayRange": "8.16 - 8.96", "regularMarketDayLow": 8.16, "regularMarketVolume": 2035, "regularMarketPreviousClose": 8.28, "bid": 8.2, "ask": 8.88, "bidSize": 10, "askSize": 22, "fullExchangeName": "NasdaqGS", "financialCurrency": "EUR", "regularMarketOpen": 8.96, "averageDailyVolume3Month": 20248, "averageDailyVolume10Day": 7760, "fiftyTwoWeekLowChange": 6.73, "fiftyTwoWeekLowChangePercent": 3.80226, "fiftyTwoWeekRange": "1.77 - 27.5", "fiftyTwoWeekHighChange": -19.0, "fiftyTwoWeekHighChangePercent": -0.6909091, "fiftyTwoWeekLow": 1.77, "fiftyTwoWeekHigh": 27.5, "earningsTimestamp": 1683543000, "earningsTimestampStart": 1683543000, "earningsTimestampEnd": 1683543000, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -2.35, "epsForward": -2.83, "epsCurrentYear": -2.83, "priceEpsCurrentYear": -3.0035336, "sharesOutstanding": 33831000, "bookValue": 4.414, "fiftyDayAverage": 8.1676, "fiftyDayAverageChange": 0.33240032, "fiftyDayAverageChangePercent": 0.04069743, "twoHundredDayAverage": 8.50377, "twoHundredDayAverageChange": -0.0037698746, "twoHundredDayAverageChangePercent": -0.00044331804, "marketCap": 305540160, "forwardPE": -3.0035336, "priceToBook": 1.925691, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-02-05", "prevName": "Pharvaris B.V.", "nameChangeDate": "2023-05-15", "averageAnalystRating": "2.0 - Buy", "tradeable": false, "cryptoTradeable": false, "displayName": "Pharvaris", "symbol": "PHVS"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Emmy Noetherweg 2", "city": "Leiden", "zip": "2333 CH", "country": "Netherlands", "phone": "31 71 203 6410", "website": "https://pharvaris.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist that is in Phase II clinical trial for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, rapid exposure soft capsule for patients suffering from acute HAE attacks which is under Phase 2 clinical trial; and PHVS719, a prophylactic extended-release tablet for HAE patients which is under Phase 1 clinical trial. It operates in the Netherlands, Switzerland, and the United States. Pharvaris N.V. was incorporated in 2015 and is based in Leiden, the Netherlands.", "fullTimeEmployees": 65, "companyOfficers": [{"maxAge": 1, "name": "Mr. Berndt Axel Edvard Modig CPA, M.B.A., MBA", "age": 63, "title": "Co-Founder, CEO & Exec. Director", "yearBorn": 1959, "fiscalYear": 2022, "totalPay": {"raw": 546800, "fmt": "546.8k", "longFmt": "546,800"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Anna  Nijdam M.Sc., R.A.", "age": 41, "title": "Head of Fin. & Principal Accounting Officer", "yearBorn": 1981, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Jochen  Knolle Ph.D.", "age": 72, "title": "Chief Scientific Officer & COO", "yearBorn": 1950, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Joan  Schmidt J.D.", "age": 58, "title": "Chief Legal Officer", "yearBorn": 1964, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Peng  Lu M.D., Ph.D.", "age": 44, "title": "Chief Medical Officer", "yearBorn": 1978, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Anne  Lesage Ph.D.", "age": 61, "title": "Chief Early Devel. Officer", "yearBorn": 1961, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Morgan  Conn Ph.D.", "age": 53, "title": "Chief Bus. Officer", "yearBorn": 1969, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Wim  Souverijns Ph.D.", "age": 51, "title": "Chief Community Engagement & Commercial Officer", "yearBorn": 1971, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Maryann  Cimino", "title": "Director of Corp. Relations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Annick  Deschoolmeester", "age": 49, "title": "Chief HR Officer", "yearBorn": 1973, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}